Abstract
Organoid systems have opened the door to modeling human tissues with a level of biological realism that conventional 2D cultures could never achieve. Yet, as many laboratories have experienced firsthand, organoids are extremely sensitive to their microenvironment and difficult to standardize across experiments. The growing shift toward smart, sensor-integrated organoid-on-a-chip platforms reflects an attempt to address these persistent challenges. These hybrid systems combine organoid biology with microfluidics, real-time sensors, microcontroller-based actuation, and increasingly, AI-driven interpretation. Together, these layers create a setting where physicochemical cues, nutrient flow, oxygen levels, and even mechanical forces can be monitored and adjusted continuously. This evolution marks a departure from the largely descriptive nature of organoid culture toward a more quantitative and automated framework. Such systems not only improve reproducibility and long-term stability but also allow organoids to reach levels of maturation and physiological behavior that are difficult to obtain in static conditions. As the technology matures, smart organoid-on-a-chip platforms are likely to play a central role in disease modeling, drug evaluation, and personalized medicine, particularly in contexts where dynamic environmental control and continuous data resolution are essential.